These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9595411)

  • 1. SB 209670 inhibits the arrhythmogenic actions of endothelin-1 in the anesthetized dog.
    Douglas SA; Nichols AJ; Feuerstein GZ; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S99-102. PubMed ID: 9595411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog.
    Kopia GA; Valocik RE; Torphy TJ; Cieslinksi LB; Sarau HM; Foley JJ; Wasserman MA
    J Pharmacol Exp Ther; 1987 Apr; 241(1):174-80. PubMed ID: 2437287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic activity of intracoronary endothelin in dogs: relation to the site of administration and to changes in regional flow.
    Salvati P; Chierchia S; Dho L; Ferrario RG; Parenti P; Vicedomini G; Patrono C
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):1007-14. PubMed ID: 1714004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1.
    Merkely B; Szabó T; Gellér L; Kiss O; Horkay F; Raschack M; Juhász-Nagy A
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S314-6. PubMed ID: 11078407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
    Cirino M; Martin E; Yano M; Rodger IW
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.
    Kiss O; Gellér L; Merkely B; Szabó T; Raschack M; Seres L; Zima E; Juhász-Nagy A; Horkay F
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S317-9. PubMed ID: 11078408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.
    Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1130-7. PubMed ID: 9399985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog.
    Nichols AJ; Koster PF; Ohlstein EH
    Br J Pharmacol; 1990 Mar; 99(3):597-601. PubMed ID: 2184913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
    Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic therapy with an ET(A/B) receptor antagonist in conscious dogs during progression of congestive heart failure. Intracellular Ca(2+) regulation and nitric oxide mediated coronary relaxation.
    Shen YT; Buie PS; Lynch JJ; Krause SM; Ma XL
    Cardiovasc Res; 2000 Nov; 48(2):332-45. PubMed ID: 11054479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bosentan the mixed endothelin-A- and -B-receptor antagonist suppresses intrapericardial endothelin-1-induced ventricular arrhythmias.
    Horkay F; Gellér L; Kiss O; Szabó T; Vagó H; Kékesi V; Juhász-Nagy A; Merkely B
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S320-2. PubMed ID: 11078409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to beta-adrenergic stimulation in normal dogs.
    Kaneko H; Endo T; Kiuchi K; Hayakawa H
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):247-54. PubMed ID: 8720424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
    Bunting MW; Widdop RE
    Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB 234551, a novel endothelin--A receptor antagonist, unmasks endothelin-induced renal vasodilatation in the dog.
    Brooks DP; DePalma PD; Pullen M; Elliott JD; Ohlstein EH; Nambi P
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S339-41. PubMed ID: 9595475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
    Douglas SA; Edwards RM; Elliott JD; Ohlstein EH
    Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unmasking of endothelin-1-induced natriuresis and renal vasodilation in the dog by enrasentan (SB 217242).
    Brooks DP; DePalma PD
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S346-7. PubMed ID: 11078416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of endothelin and Bay k 8644 on cardiohemodynamics in anesthetized pigs.
    Adachi H; Shoji T; Goto K
    Eur J Pharmacol; 1991 Jan; 193(1):57-65. PubMed ID: 1710988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel model of conduit coronary constriction reveals local actions of endothelin-1 and prostaglandin F2alpha.
    Rigel DF; Shetty SS
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H2054-64. PubMed ID: 9139993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trigeminal nerve ganglion stimulation-induced neurovascular reflexes in the anaesthetized cat: role of endothelin(B) receptors in carotid vasodilatation.
    Raval P; Bingham S; Aiyar N; Elliott JD; Hunter AJ; Ohlstein EH; Parsons AA
    Br J Pharmacol; 1999 Jan; 126(2):485-93. PubMed ID: 10077242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism.
    Rasmussen TE; Jougasaki M; Supaporn T; Hallett JW; Brooks DP; Burnett JC
    Am J Physiol; 1998 Jan; 274(1):R131-8. PubMed ID: 9458909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.